On Tuesday, supporters of Measure 109 came together virtually to talk about the mental health benefits of the drug.
If passed, this measure would allow the manufacture, delivery and administration of psilocybin at supervised, licensed facilities to adults aged 21 and over.
Currently, the manufacturing and consumption of this drug is illegal under both state and federal law.
Supporters say psilocybin therapy relieves debilitating anxiety and depression that comes with a terminal illness.
On the Zoom call Tuesday, attendees heard from a cancer patient in Portland who has a terminal diagnosis.
Mara McGraw says she underwent psilocybin therapy with a trained facilitator recently after trying other options.
“In just one session, I feel tremendous relief from fear and anxiety that had been burdening me for three years now, and I did not receive that type of relief through a year of talk therapy. So, one session gave me more than going weekly to talk therapy for an entire year,” said McGraw.